BIRD(SH:600130)2021-10-28 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥150,796,358.99, a decrease of 45.53% compared to the same period last year[6]. - The net profit attributable to shareholders for Q3 2021 was -¥2,235,068.48, a decline of 132.90% year-on-year[12]. - The basic earnings per share for Q3 2021 was -¥0.003, representing a decrease of 133.33% compared to the previous year[7]. - The company reported a net profit of ¥27,650,741.37 for the year-to-date, a decrease of 18.48% compared to the same period last year[6]. - Total operating revenue for the first three quarters of 2021 reached ¥567.43 million, a 40.4% increase from ¥404.05 million in the same period of 2020[20]. - Net profit for the first three quarters of 2021 was ¥35.45 million, slightly up from ¥35.21 million in the previous year, indicating a growth of 0.67%[20]. - Operating profit for the first three quarters of 2021 was ¥38.00 million, down 14.7% from ¥44.47 million in the same period of 2020[20]. - The company reported a total comprehensive income of ¥35.48 million for the first three quarters of 2021, compared to ¥35.28 million in the previous year[21]. - Basic and diluted earnings per share for the first three quarters of 2021 were both ¥0.036, down from ¥0.044 in the same period of 2020[21]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,207,615,790.54, a decrease of 3.50% from the end of the previous year[7]. - As of September 30, 2021, the total assets of the company amounted to CNY 1,207,615,790.54, a decrease from CNY 1,251,363,164.66 at the end of 2020, reflecting a decline of approximately 3.5%[18]. - The company's current assets totaled CNY 940,522,236.72, down from CNY 976,701,173.46 at the end of 2020, indicating a decrease of about 3.7%[17]. - The company's total liabilities were CNY 209,403,712.05, a decrease from CNY 297,281,995.27, representing a reduction of approximately 29.5%[18]. - Total assets amounted to 1,251,363,164.66, with current assets at 976,701,173.46 and non-current assets at 274,661,991.20[26]. - Total liabilities reached 297,281,995.27, with current liabilities at 291,167,400.70 and non-current liabilities at 6,114,594.57[27]. - Shareholders' equity totaled 954,081,169.39, with equity attributable to the parent company at 938,023,617.05[27]. - The total liabilities to equity ratio stands at approximately 0.31, suggesting a moderate level of leverage[27]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥41,824,531.54, with significant changes in receivables contributing to this figure[11]. - Cash flow from operating activities showed a net inflow of ¥41.82 million, a significant improvement compared to a net outflow of ¥79.92 million in the same period of 2020[24]. - Total cash and cash equivalents at the end of the period were ¥263.65 million, compared to ¥45.40 million at the end of the same period in 2020[24]. - Cash and cash equivalents stood at CNY 277,325,579.72, down from CNY 292,915,103.90, reflecting a decrease of approximately 5.3%[17]. - The company received cash inflow of ¥17.15 million from minority shareholders during the financing activities, marking a new source of funding[24]. Shareholder Information - The company has a total of 70,357 ordinary shareholders at the end of the reporting period[13]. - The company's equity attributable to shareholders was CNY 965,709,467.14, an increase from CNY 938,023,617.05, showing a growth of about 3.0%[18]. - The total equity increased to CNY 998,212,078.49 from CNY 954,081,169.39, representing an increase of approximately 4.6%[18]. Other Financial Metrics - The weighted average return on equity decreased by 0.97 percentage points to -0.23% at the end of the reporting period[7]. - The company experienced a 584.97% increase in net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2021, primarily due to changes in product composition[12]. - The company recorded non-recurring gains of ¥11,927,041.51 from the disposal of non-current assets during the year-to-date[9]. - Research and development expenses increased significantly to ¥11.69 million, up 109.9% from ¥5.57 million in the same period of 2020[20]. - Investment activities resulted in a net cash outflow of ¥59.66 million, an improvement from a net outflow of ¥177.22 million in the same period of 2020[24]. - The company reported a negative retained earnings of -357,292,455.40, indicating accumulated losses[27]. - The capital reserve was recorded at 455,922,182.76, reflecting the company's financial stability[27]. - The company has a short-term loan of 23,024,379.17, indicating reliance on external financing[26]. - The company has a deferred income of 5,337,679.96, which may indicate future revenue recognition[27].